News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,703 Results
Type
Article (582)
Company Profile (4)
Press Release (4117)
Section
Business (1342)
Career Advice (17)
Deals (155)
Drug Delivery (2)
Drug Development (418)
Employer Resources (1)
FDA (69)
Job Trends (90)
News (1941)
Policy (93)
Tag
2027 Biotech Bay Standard (1)
Academia (75)
Accelerated approval (1)
Alliances (350)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (2)
Approvals (68)
Artificial intelligence (3)
Bankruptcy (1)
Best Places to Work (64)
Biotechnology (2)
Breast cancer (18)
Cancer (46)
Cardiovascular disease (4)
Career advice (15)
CAR-T (2)
Cell therapy (8)
Clinical research (308)
Collaboration (14)
Compensation (1)
COVID-19 (17)
CRISPR (2)
C-suite (9)
Cystic fibrosis (4)
Data (46)
Diabetes (2)
Diagnostics (43)
Drug discovery (1)
Earnings (350)
Employer resources (1)
Events (656)
Executive appointments (13)
FDA (81)
Funding (19)
Gene editing (7)
Gene therapy (6)
GLP-1 (4)
Government (24)
Guidances (2)
Healthcare (95)
Immunology and inflammation (1)
Infectious disease (19)
Inflammatory bowel disease (1)
Influenza (1)
Intellectual property (3)
Interviews (2)
IPO (64)
Job creations (21)
Job search strategy (15)
Labor market (1)
Layoffs (2)
Legal (15)
Lung cancer (3)
Lymphoma (5)
Machine learning (2)
Manufacturing (12)
Medical device (88)
Medtech (89)
Mergers & acquisitions (103)
Metabolic disorders (3)
Neuroscience (6)
NextGen: Class of 2026 (51)
Non-profit (28)
Now hiring (1)
Obesity (1)
Opinion (1)
Pancreatic cancer (1)
Parkinson's disease (3)
Patents (5)
Patient recruitment (1)
People (590)
Pharmaceutical (1)
Phase 1 (159)
Phase 2 (147)
Phase 3 (55)
Pipeline (33)
Postmarket research (4)
Preclinical (106)
Press Release (5)
Prostate cancer (7)
Radiopharmaceuticals (1)
Rare diseases (6)
Real estate (53)
Recruiting (1)
Regulatory (71)
Reports (3)
Research institute (63)
Resumes & cover letters (3)
Series A (4)
Series B (1)
Startups (47)
Vaccines (2)
Venture capital (1)
Date
Last 7 days (2)
Last 30 days (11)
Last 365 days (217)
2026 (15)
2025 (232)
2024 (246)
2023 (293)
2022 (417)
2021 (417)
2020 (311)
2019 (293)
2018 (237)
2017 (234)
2016 (294)
2015 (312)
2014 (185)
2013 (126)
2012 (128)
2011 (209)
2010 (159)
Location
Africa (5)
Alabama (1)
Arizona (1)
Arkansas (1)
Asia (452)
Australia (39)
California (71)
Canada (9)
China (8)
Colorado (2)
Connecticut (50)
Europe (358)
Florida (9)
Illinois (2)
Indiana (1)
Maryland (11)
Massachusetts (48)
Michigan (6)
Minnesota (10)
New Jersey (12)
New Mexico (2)
New York (26)
North Carolina (79)
Northern California (35)
Ohio (1)
Oklahoma (1)
Pennsylvania (9)
South America (8)
Southern California (25)
Texas (17)
United States (343)
Utah (2)
Washington State (8)
4,703 Results for "chimera bioengineering".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Proteolysis Targeting Chimeras (PROTACs) In Cancer Therapy
October 10, 2024
·
3 min read
Genetown
Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual Meeting
Avilar Therapeutics today announced it will present preclinical proof-of-concept data for the company’s MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGY™ 2024, the American Association of Immunologists annual meeting.
May 1, 2024
·
3 min read
Asian Fund for Cancer Research Announces Chimera Bioengineering as the 2021 BRACE Award Venture Competition Winner
Chimera Bioengineering has been selected as the winner of the Asian Fund for Cancer Research’s (AFCR) 2021 BRACE Award Venture Competition —a first-of-its-kind program for early stage oncology technology companies focused on Asian-prevalent cancers.
April 28, 2022
·
4 min read
Press Releases
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
September 30, 2025
·
7 min read
Press Releases
Regenerative Patch Technologies (RPT) Announces Treatment of First Two Patients in Phase IIb Clinical Trial Assessing the Safety and Efficacy of its Allogeneic Bioengineered RPE Cell Implant for the Treatment of Advanced Dry Age-Related Macular Degeneration.
December 10, 2025
·
4 min read
Press Releases
United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver
June 24, 2025
·
8 min read
Business
Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors
Chimera Bioengineering a biotherapeutics company building next-generation CAR-T therapeutics focused primarily on solid tumors, announced the appointment of Vlad Hogenhuis, M.D., as Chief Executive Officer.
April 28, 2022
·
5 min read
Pharm Country
Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference
Cell BioEngines, Inc. announced that Dr. Ajay Vishwakarma, Founder and CEO of Cell BioEngines, will be presenting at the BIO CEO & Investor Conference at 2:00 p.m. EST on Monday, February 26, 2024.
February 8, 2024
·
2 min read
Business
Taking a Page from Nature’s Playbook, Chimera Wins Coveted BRACE Award
Chimera’s research comes largely from its GOLD platform, a technology that reprograms RNA gene regulation circuits to alter chimeric antigen receptors (CAR) on T cells.
April 28, 2022
·
3 min read
·
Hannah Chudleigh
BioCapital
Pantheon Vision Secures a Second Tranche of $1.8 Million to Advance Bioengineered Corneal Implants
Pantheon Vision Secures a Second Tranche of $1.8 Million to Advance Bioengineered Corneal Implants.
April 2, 2024
·
2 min read
1 of 471
Next
